A detailed history of Citigroup Inc transactions in Novartis Ag stock. As of the latest transaction made, Citigroup Inc holds 294,178 shares of NVS stock, worth $28.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
294,178
Previous 251,536 16.95%
Holding current value
$28.9 Million
Previous $26.8 Million 26.36%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$106.13 - $120.89 $4.53 Million - $5.15 Million
42,642 Added 16.95%
294,178 $33.8 Million
Q2 2024

Aug 12, 2024

SELL
$92.57 - $107.37 $61.5 Million - $71.4 Million
-664,628 Reduced 72.54%
251,536 $26.8 Million
Q1 2024

May 10, 2024

BUY
$95.27 - $108.47 $64.4 Million - $73.3 Million
676,034 Added 281.53%
916,164 $88.6 Million
Q4 2023

Feb 09, 2024

BUY
$92.27 - $101.54 $5.11 Million - $5.63 Million
55,429 Added 30.01%
240,130 $24.2 Million
Q3 2023

Nov 09, 2023

BUY
$94.73 - $105.13 $68,679 - $76,219
725 Added 0.39%
184,701 $18.8 Million
Q2 2023

Aug 10, 2023

SELL
$92.52 - $104.91 $10.3 Million - $11.7 Million
-111,575 Reduced 37.75%
183,976 $18.6 Million
Q1 2023

May 11, 2023

BUY
$80.03 - $92.81 $9.52 Million - $11 Million
119,005 Added 67.41%
295,551 $27.2 Million
Q4 2022

Feb 09, 2023

BUY
$75.55 - $92.52 $635,753 - $778,555
8,415 Added 5.01%
176,546 $16 Million
Q3 2022

Nov 10, 2022

BUY
$74.61 - $87.26 $105,946 - $123,909
1,420 Added 0.85%
168,131 $12.8 Million
Q2 2022

Aug 10, 2022

BUY
$80.52 - $93.75 $19,727 - $22,968
245 Added 0.15%
166,711 $14.1 Million
Q1 2022

May 12, 2022

BUY
$80.11 - $90.62 $1.02 Million - $1.15 Million
12,745 Added 8.29%
166,466 $14.6 Million
Q4 2021

Feb 10, 2022

SELL
$79.7 - $88.13 $3.35 Million - $3.7 Million
-42,016 Reduced 21.47%
153,721 $13.4 Million
Q3 2021

Nov 10, 2021

BUY
$81.78 - $95.14 $16 Million - $18.6 Million
195,737 New
195,737 $16 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.